The importance of bactericidal drugs: future directions in infectious disease. - Wikidata - awgldk - TriplyDB

The importance of bactericidal drugs: future directions in infectious disease.

The importance of bactericidal drugs: future directions in infectious disease.

http://www.wikidata.org/entity/Q34360508

about

Antimicrobial agents for preventing urinary tract infections in patients undergoing cystoscopy Discovery of Inhibitors of 4'-Phosphopantetheine Adenylyltransferase (PPAT) To Validate PPAT as a Target for Antibacterial Therapy Postoperative meningitis after spinal surgery: a review of 21 cases from 20,178 patients Short-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations.Daptomycin versus vancomycin for complicated skin and skin structure infections: clinical and economic outcomes.Tuning the composition of AuPt bimetallic nanoparticles for antibacterial application Impact of the combination of daptomycin and trimethoprim-sulfamethoxazole on clinical outcomes in methicillin-resistant Staphylococcus aureus infections.Synthesis and antibacterial evaluation of a novel series of synthetic phenylthiazole compounds against methicillin-resistant Staphylococcus aureus (MRSA).Anti-biofilm activity and synergism of novel thiazole compounds with glycopeptide antibiotics against multidrug-resistant staphylococci.Rapid bactericidal activity of daptomycin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus peritonitis in mice as measured with bioluminescent bacteria.Antibiotic efficacy is linked to bacterial cellular respiration.Membrane-active action mode of polybia-CP, a novel antimicrobial peptide isolated from the venom of Polybia paulista.Empiric antimicrobial therapy in severe sepsis and septic shock: optimizing pathogen clearance Synthesis and Complete Antimicrobial Characterization of CEOBACTER, an Ag-Based Nanocomposite Microbiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains.Potential impact of vancomycin pulmonary distribution on treatment outcomes in patients with methicillin-resistant Staphylococcus aureus pneumonia.Current concepts in the treatment of bacterial meningitis beyond the neonatal period.Learning from bacteriophages - advantages and limitations of phage and phage-encoded protein applications.Vancomycin: does it still have a role as an antistaphylococcal agent?Efficacy of iclaprim against wild-type and thymidine kinase-deficient methicillin-resistant Staphylococcus aureus isolates in an in vitro fibrin clot model.Emerging drugs for acute bacterial meningitis.An alternate pathophysiologic paradigm of sepsis and septic shock: implications for optimizing antimicrobial therapy.Invasive community-associated MRSA infections: epidemiology and antimicrobial management.Combination antibiotic therapy for the treatment of infective endocarditis due to enterococci.Translational Pharmacometric Evaluation of Typical Antibiotic Broad-Spectrum Combination Therapies Against Staphylococcus Aureus Exploiting In Vitro Information In vitro bacteriostatic effects of rifampin on Orientia tsutsugamushi.Development of ruthenium(II) complexes as topical antibiotics against methicillin resistant Staphylococcus aureus.In vitro activity of dalbavancin and five comparator agents against common and uncommon Gram-positive organisms isolated from cancer patients.Evaluation of the novel combination of high-dose daptomycin plus trimethoprim-sulfamethoxazole against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus using an in vitro pharmacokinetic/pharmacodynamic model of simulated endocar Superoxide-mediated protection of Escherichia coli from antimicrobials.In vitro activity of telavancin compared with vancomycin and linezolid against Gram-positive organisms isolated from cancer patients.Daptomycin use in neutropenic patients with documented gram-positive infections.Evaluation of daptomycin pharmacodynamics and resistance at various dosage regimens against Staphylococcus aureus isolates with reduced susceptibilities to daptomycin in an in vitro pharmacodynamic model with simulated endocardial vegetations.Pharmacodynamics of a simulated single 1,200-milligram dose of oritavancin in an in vitro pharmacokinetic/pharmacodynamic model of methicillin-resistant staphylococcus aureus infection.Isotope ratio-based profiling of microbial folates.Assessment by time-kill methodology of the synergistic effects of oritavancin in combination with other antimicrobial agents against Staphylococcus aureus.Candida meningitis post Gliadel wafer placement successfully treated with intrathecal and intravenous amphotericin B.Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.The in vitro, in vivo antifungal activity and the action mode of Jelleine-I against Candida species.Alkynyl-containing phenylthiazoles: Systemically active antibacterial agents effective against methicillin-resistant Staphylococcus aureus (MRSA).

P2860

Q26470640-CA22A90A-F620-4452-9B22-6128E1756FD4 Q27679964-C1C7D85C-2CB5-4452-9BE9-E8A91E07ADAB Q33581401-ED7E4189-D39A-44B4-8CE8-0D4E35087227 Q33883648-3BE6BD4A-48BF-4441-9F7D-1D52D6AD1A50 Q34718540-F982D3A1-6C2B-422F-9F66-E66057933641 Q35061102-79D519A4-CCF0-40C7-945D-8B8772699FEE Q35169018-A5FDA852-5636-4A0D-9008-7A53E78F7C5D Q35577377-B58A2DB5-47E6-41A9-A008-D73736C80192 Q35599090-9C76843F-2019-4616-9327-61D9713473EC Q35759049-56AF8B47-6B9A-423F-824F-32A221BE46BA Q35845962-9DFCE1D9-92C4-4CAB-A021-3C987D85D032 Q36018834-26EE5009-694D-4C13-8B43-E0CB3C92C5BE Q36089167-75549746-A93D-40A7-9868-3F7649119098 Q36185778-734A707D-32BF-4DB3-B771-E9EE8D3AB83C Q36328966-C75D3048-6CCF-4306-B814-3BA15EC2C941 Q36428418-AB036256-5699-46A2-AB99-ED58557B817C Q36607421-E9465FD4-775F-409C-9C33-C789437150EF Q36676044-331BD74D-AC3D-4CBD-87FD-6B61155540CF Q36839712-D20BADAF-CEF7-45B5-97BB-CF8FAEEADEEB Q37333096-77F943B9-86CF-42CE-A744-0F570340A591 Q37558543-F2B529AC-A68A-49B0-8A37-82AC5178B30C Q37563029-01262E6D-3F81-4626-8455-7B36E827A3EF Q37800939-86CF4424-9202-4590-93CF-DFE88BDB9391 Q38577676-B9257368-BB62-4020-98E2-3C40DBBE877A Q38853629-E240F5AA-EB39-4C5D-A270-73D7573F30FB Q39022677-5EB4E7DC-F98E-4893-BF8E-5BDAD52BE12A Q39032141-1945859F-EBB6-4286-96E5-14BD59E79CC6 Q40252885-A61DA42E-D980-47A2-984C-2DFA07C477D4 Q41570351-A45FBBA3-39E7-4214-8978-81DFA6869889 Q42116431-8A3A96D0-7665-4234-9B69-E20F7B635728 Q42215430-96BA7703-9979-4B04-84AD-32BCA64F61D3 Q42249906-22C221AE-CF28-4A87-8E4A-67A3FC7C7611 Q42445383-13E69938-FFD6-4184-A43E-3EEB4211F8CE Q42530056-5E7E3C36-B9AC-4995-922F-4A1D4C7ADCA3 Q42702892-98531C63-FB2F-405D-BCC0-EC2DFEC9EEC5 Q43189837-4C93C47B-C2C4-4AFD-B387-796792B13356 Q43211363-120337A1-D577-4498-9993-4CC53C9BDC63 Q43834023-78A21D91-1F9D-4055-99BE-B7CDA9DA97B5 Q46269107-1015B07A-88F9-4AFA-A0A5-17426CB6D6D5 Q49833719-E156BB50-001E-48EF-B7E9-AC4629C42792

P2860

The importance of bactericidal drugs: future directions in infectious disease.

http://www.wikidata.org/entity/Q34360508

description

2004 nî lūn-bûn

@nan

2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

The importance of bactericidal drugs: future directions in infectious disease.

@ast

The importance of bactericidal drugs: future directions in infectious disease.

@en

The importance of bactericidal drugs: future directions in infectious disease.

@nl

type

label

The importance of bactericidal drugs: future directions in infectious disease.

@ast

The importance of bactericidal drugs: future directions in infectious disease.

@en

The importance of bactericidal drugs: future directions in infectious disease.

@nl

prefLabel

The importance of bactericidal drugs: future directions in infectious disease.

@ast

The importance of bactericidal drugs: future directions in infectious disease.

@en

The importance of bactericidal drugs: future directions in infectious disease.

@nl

P1433

Q34360508-54DFC947-DDB7-4204-94CC-37152BF58BEF

P1476

Q34360508-E6CB294C-0248-4F04-9971-7032CAE1F2AE

P2093

Q34360508-0809ACF2-D64F-464D-A195-D68BDCFBA31A

Q34360508-131249BB-D68D-4E72-B3A3-4B96DF67D4A0

Q34360508-50513EF2-86B0-477B-B5FA-DE4E0218A133

Q34360508-63337697-6B8C-4E77-BAB8-C8601CC27ECA

Q34360508-7549BF0E-8F1B-4683-AF5C-F78F7631134C

Q34360508-7B2A9133-8CD8-4228-AA08-4D89A59407EF

Q34360508-7F06B099-4353-4786-9E83-9EC331E3C00F

Q34360508-8FC54AB7-7645-4F01-9BAA-D910C7BBA0B9

Q34360508-B724EA9C-6926-4D00-BC4F-295E6D346BA1

Q34360508-E46A89BB-CE84-45B1-A62A-2A2A6ABB1931

P304

Q34360508-81D74848-4F2B-4176-A961-A520DFD4AE01

P31

Q34360508-0E9E0FAD-1011-4DF5-8F02-4CDD61BA58BC

P356

Q34360508-1A9ECE82-7949-4F9E-9162-D65A4E068DB4

P407

Q34360508-9D675E25-BFC9-44FD-985F-D767E4DBAD1C

P433

Q34360508-447481E5-C493-431E-9B0C-7C5EC816B27E

P478

Q34360508-DD15FDA7-B3E9-4994-A476-948B9FDAC2E5

P50

Q34360508-4773E6BB-9AE3-40D5-A9A2-7442C17828FE

P577

Q34360508-F4FB38BB-307E-40BF-B2AC-43443CEB3FD6

P5875

Q34360508-8F9FBEB1-D3B8-4861-B6D8-1D343DBBCB1D

P698

Q34360508-7DB60337-1305-417F-B750-E263E5D07A3E

P356

P1433

Clinical Infectious Diseases

P1476

The importance of bactericidal drugs: future directions in infectious disease

@en

P2093

E Patchen Dellinger

http://www.w3.org/2001/XMLSchema#string

Francis P Tally

http://www.w3.org/2001/XMLSchema#string

George A Pankey

http://www.w3.org/2001/XMLSchema#string

John C Rotschafer

http://www.w3.org/2001/XMLSchema#string

Ken V Rolston

http://www.w3.org/2001/XMLSchema#string

Manjari Joshi

http://www.w3.org/2001/XMLSchema#string

Michael J Rybak

http://www.w3.org/2001/XMLSchema#string

Peter K Linden

http://www.w3.org/2001/XMLSchema#string

Robert C Moellering

http://www.w3.org/2001/XMLSchema#string

Robert W Finberg

http://www.w3.org/2001/XMLSchema#string

P304

1314-1320

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/425009

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

39

http://www.w3.org/2001/XMLSchema#string

P50

Michaela A West

P577

2004-10-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8222005

http://www.w3.org/2001/XMLSchema#string

P698

15494908

http://www.w3.org/2001/XMLSchema#string